Market Cap 4.56M
Revenue (ttm) 0.00
Net Income (ttm) -18.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 59,000
Avg Vol 249,966
Day's Range N/A - N/A
Shares Out 5.21M
Stochastic %K 58%
Beta 1.14
Analysts Sell
Price Target $8.00

Company Profile

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It al...

Industry: Biotechnology
Sector: Healthcare
Phone: 281 671 5150
Address:
455 East Medical Center Boulevard, Suite 300, Houston, United States
Niddi
Niddi Jul. 1 at 2:46 PM
$FBLG The sp was obviously manipulated down to $.75 to grant these options and $ 9 million private placement. Now it is so smoothly going above critical value of $1 without problem. All is well, nothing to look here SEC!!!!
0 · Reply
Mountain_Skis
Mountain_Skis Jun. 30 at 10:05 PM
$JEM being patient paid off 🙏🏽 Waiting for $FBLG
0 · Reply
Mountain_Skis
Mountain_Skis Jun. 30 at 3:26 PM
$JEM finally round 3 paid off. $FBLG just needs a solid push 🔥
0 · Reply
MisoHawny
MisoHawny Jun. 29 at 7:33 PM
$FBLG 0.73 on deck
0 · Reply
Majid74
Majid74 Jun. 26 at 10:11 PM
$FBLG why is it again down?
0 · Reply
Enoch120
Enoch120 Jun. 26 at 6:08 PM
$FBLG breathing a little sigh of relief with new lower cost average. i know this will take awhile for trials to advance. 🙏
0 · Reply
JMJTrading
JMJTrading Jun. 26 at 4:14 PM
0 · Reply
JMJTrading
JMJTrading Jun. 26 at 2:37 PM
$FBLG buy alert, retesting the 75 cents, if it holds, we see abouve 85, break that and we could see $1 today.
0 · Reply
Niddi
Niddi Jun. 26 at 2:33 PM
$FBLG Heading back to $1
1 · Reply
JMJTrading
JMJTrading Jun. 26 at 2:10 PM
Headed to $FBLG with SLS profits! 4.55 million share float FBLG announced a definitive agreement for a $9.0 million private placement. They secured $3.0 million with up to $6.0 million in potential additional gross proceeds upon the full exercise of accompanying warrants. $FBLG) is executing a very clean, steady move to the upside so far this morning. break 85 cents and this will soar. $MTEN $GPUS $SLS @LosersMakeMillions @DavidScott @topstockalerts
0 · Reply
Latest News on FBLG
FibroBiologics Transcript: AGM 2026

Jun 22, 2026, 12:00 PM EDT - 12 days ago

FibroBiologics Transcript: AGM 2026


FibroBiologics receives notice of allowance for U.S. patent

2026-06-22T13:39:09.000Z - 12 days ago

FibroBiologics receives notice of allowance for U.S. patent


FibroBiologics doses first patients in CYWC628 clinical trial

2026-06-16T12:58:52.000Z - 18 days ago

FibroBiologics doses first patients in CYWC628 clinical trial


FibroBiologics doses first patients in CYWC628 trial

2026-06-03T12:30:49.000Z - 4 weeks ago

FibroBiologics doses first patients in CYWC628 trial


FibroBiologics presents preclinical data from CYPS317 program

2026-05-22T12:45:44.000Z - 6 weeks ago

FibroBiologics presents preclinical data from CYPS317 program


FibroBiologics CEO Issues Letter to Shareholders

May 5, 2026, 8:30 AM EDT - 2 months ago

FibroBiologics CEO Issues Letter to Shareholders


FibroBiologics Proxy statement: Proxy filing

May 5, 2026, 8:00 AM EDT - 2 months ago

FibroBiologics Proxy statement: Proxy filing


FibroBiologics Proxy statement: Proxy filing

May 5, 2026, 8:00 AM EDT - 2 months ago

FibroBiologics Proxy statement: Proxy filing


FibroBiologics downgraded to Hold from Buy at Maxim

2026-05-04T12:28:08.000Z - 2 months ago

FibroBiologics downgraded to Hold from Buy at Maxim


FibroBiologics reports Q1 net loss roughly ($5M)

2026-04-30T22:00:27.000Z - 2 months ago

FibroBiologics reports Q1 net loss roughly ($5M)


FibroBiologics Quarterly report: Q1 2026

Apr 30, 2026, 7:00 AM EDT - 2 months ago

FibroBiologics Quarterly report: Q1 2026


FibroBiologics Earnings release: Q1 2026

Apr 30, 2026, 7:00 AM EDT - 2 months ago

FibroBiologics Earnings release: Q1 2026


FibroBiologics Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

FibroBiologics Proxy statement: Proxy filing


FibroBiologics Compliant with All Nasdaq Listing Requirements

Apr 20, 2026, 4:01 PM EDT - 2 months ago

FibroBiologics Compliant with All Nasdaq Listing Requirements


FibroBiologics Announces Closing of $3 Million Public Offering

Apr 2, 2026, 4:01 PM EDT - 3 months ago

FibroBiologics Announces Closing of $3 Million Public Offering


FibroBiologics prices $3M public offering

2026-04-01T00:05:13.000Z - 3 months ago

FibroBiologics prices $3M public offering


FibroBiologics Announces Pricing of $3 Million Public Offering

Mar 31, 2026, 8:00 PM EDT - 3 months ago

FibroBiologics Announces Pricing of $3 Million Public Offering


Fibrobiologics Inc trading halted, news pending

2026-03-27T23:50:16.000Z - 3 months ago

Fibrobiologics Inc trading halted, news pending


FibroBiologics Registration statement: Registration filing

Mar 27, 2026, 8:00 AM EDT - 3 months ago

FibroBiologics Registration statement: Registration filing


FibroBiologics downgraded to Hold from Buy at D. Boral Capital

2026-03-26T11:21:11.000Z - 3 months ago

FibroBiologics downgraded to Hold from Buy at D. Boral Capital


FibroBiologics announces 1-for-20 reverse stock split

2026-03-25T20:50:15.000Z - 3 months ago

FibroBiologics announces 1-for-20 reverse stock split


FibroBiologics announces expansion of wound care platform

2026-03-12T12:48:33.000Z - 4 months ago

FibroBiologics announces expansion of wound care platform


FibroBiologics to Present at the BIO Investment & Growth Summit

Feb 26, 2026, 8:30 AM EST - 4 months ago

FibroBiologics to Present at the BIO Investment & Growth Summit


FibroBiologics Earnings release: Q4 2025

Feb 24, 2026, 7:00 AM EST - 4 months ago

FibroBiologics Earnings release: Q4 2025


FibroBiologics Annual report: Q4 2025

Feb 24, 2026, 7:00 AM EST - 4 months ago

FibroBiologics Annual report: Q4 2025


FibroBiologics Annual report: Q4 2025

Feb 24, 2026, 7:00 AM EST - 4 months ago

FibroBiologics Annual report: Q4 2025


FibroBiologics Granted Extension by Nasdaq to Regain Compliance

Feb 23, 2026, 8:30 AM EST - 4 months ago

FibroBiologics Granted Extension by Nasdaq to Regain Compliance


FibroBiologics Transcript: EGM 2026

Feb 20, 2026, 12:00 PM EST - 4 months ago

FibroBiologics Transcript: EGM 2026


FibroBiologics to Present at the DealFlow Discovery Conference

Jan 20, 2026, 8:30 AM EST - 5 months ago

FibroBiologics to Present at the DealFlow Discovery Conference


FibroBiologics Proxy statement: Proxy Filing

Dec 29, 2025, 7:00 AM EST - 6 months ago

FibroBiologics Proxy statement: Proxy Filing


FibroBiologics Proxy statement: Proxy Filing

Dec 29, 2025, 7:00 AM EST - 6 months ago

FibroBiologics Proxy statement: Proxy Filing


FibroBiologics Registration statement: Registration Filing

Dec 23, 2025, 7:00 AM EST - 6 months ago

FibroBiologics Registration statement: Registration Filing


FibroBiologics Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 7 months ago

FibroBiologics Proxy statement: Proxy Filing


FibroBiologics Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 7 months ago

FibroBiologics Proxy statement: Proxy Filing


FibroBiologics Announces Payoff of Outstanding Debt

Nov 26, 2025, 8:30 AM EST - 7 months ago

FibroBiologics Announces Payoff of Outstanding Debt


FibroBiologics Earnings release: Q3 2025

Oct 31, 2025, 4:00 PM EDT - 8 months ago

FibroBiologics Earnings release: Q3 2025


FibroBiologics Quarterly report: Q3 2025

Oct 31, 2025, 4:00 PM EDT - 8 months ago

FibroBiologics Quarterly report: Q3 2025


FibroBiologics to Present at Bio-Europe 2025

Oct 24, 2025, 8:30 AM EDT - 9 months ago

FibroBiologics to Present at Bio-Europe 2025


FibroBiologics to Present at the 2025 ThinkEquity Conference

Oct 14, 2025, 8:30 AM EDT - 9 months ago

FibroBiologics to Present at the 2025 ThinkEquity Conference


FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa

Sep 23, 2025, 8:30 AM EDT - 10 months ago

FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa


Niddi
Niddi Jul. 1 at 2:46 PM
$FBLG The sp was obviously manipulated down to $.75 to grant these options and $ 9 million private placement. Now it is so smoothly going above critical value of $1 without problem. All is well, nothing to look here SEC!!!!
0 · Reply
Mountain_Skis
Mountain_Skis Jun. 30 at 10:05 PM
$JEM being patient paid off 🙏🏽 Waiting for $FBLG
0 · Reply
Mountain_Skis
Mountain_Skis Jun. 30 at 3:26 PM
$JEM finally round 3 paid off. $FBLG just needs a solid push 🔥
0 · Reply
MisoHawny
MisoHawny Jun. 29 at 7:33 PM
$FBLG 0.73 on deck
0 · Reply
Majid74
Majid74 Jun. 26 at 10:11 PM
$FBLG why is it again down?
0 · Reply
Enoch120
Enoch120 Jun. 26 at 6:08 PM
$FBLG breathing a little sigh of relief with new lower cost average. i know this will take awhile for trials to advance. 🙏
0 · Reply
JMJTrading
JMJTrading Jun. 26 at 4:14 PM
0 · Reply
JMJTrading
JMJTrading Jun. 26 at 2:37 PM
$FBLG buy alert, retesting the 75 cents, if it holds, we see abouve 85, break that and we could see $1 today.
0 · Reply
Niddi
Niddi Jun. 26 at 2:33 PM
$FBLG Heading back to $1
1 · Reply
JMJTrading
JMJTrading Jun. 26 at 2:10 PM
Headed to $FBLG with SLS profits! 4.55 million share float FBLG announced a definitive agreement for a $9.0 million private placement. They secured $3.0 million with up to $6.0 million in potential additional gross proceeds upon the full exercise of accompanying warrants. $FBLG) is executing a very clean, steady move to the upside so far this morning. break 85 cents and this will soar. $MTEN $GPUS $SLS @LosersMakeMillions @DavidScott @topstockalerts
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 26 at 12:31 PM
$FBLG FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
0 · Reply
Niddi
Niddi Jun. 25 at 12:24 AM
$FBLG There you go again (the last minute drop). I will continue to average down. Let’s see how far it goes like this. At one point with good news, it will reverse itself. The lower it drops, the higher ultimate gain will be. Just my opinion.
0 · Reply
MisoHawny
MisoHawny Jun. 24 at 12:29 AM
$FBLG C level execs were each just granted options to purchase 30 K shares at $.75. 
1 · Reply
Wnt531
Wnt531 Jun. 23 at 4:39 PM
$FBLG is one of the most overlooked biotech plays on the market. Revolutionary fibroblast technology, huge potential across multiple diseases, and still flying under the radar. I’m loading up and holding tight because when Wall Street finally catches on, this thing is going straight to the moon.
1 · Reply
silentmaxx
silentmaxx Jun. 23 at 2:47 PM
0 · Reply
Niddi
Niddi Jun. 22 at 6:11 PM
0 · Reply
_Christ_is_King_
_Christ_is_King_ Jun. 22 at 1:57 PM
$FBLG https://www.stocktitan.net/news/FBLG/fibro-biologics-receives-notice-of-allowance-for-u-s-patent-covering-6u1s97nfzq3j.html
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 22 at 12:31 PM
$FBLG FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing
0 · Reply
Niddi
Niddi Jun. 17 at 7:24 PM
$FBLG Infiltrated by manipulators. Bought more. Cheapies!
0 · Reply
Niddi
Niddi Jun. 16 at 4:39 PM
$FBLG It’s very obvious at level II that some immature short is trying to manipulate the price by fixing buy/sell price. I am adding. It’s just a matter of time before a significant news will be released and this will jump up.
1 · Reply
Niddi
Niddi Jun. 16 at 4:16 PM
$FBLG It’s being shorted.
0 · Reply
Niddi
Niddi Jun. 16 at 2:45 PM
$FBLG Good value to add.
0 · Reply